Active ingredientTanomastatCat. No. P-T016-001CAS 179545-77-8Family · Pharmaceutical analytical standards
Tanomastat
An oral, non-peptide matrix metalloproteinase inhibitor with a biphenyl structure: in the late 1990s it was studied as an anticancer agent able to curb angiogenesis, in trials on lung, pancreatic and ovarian tumours. This family brings together the active ingredient and other impurities.
Did you know?It was highly selective: it hit mainly MMP-2 and MMP-9, sparing the collagenases MMP-1 and MMP-13 that were inhibited by other similar molecules of the time.
Go to the active ingredient →Active ingredientTanomastatCat. No. P-T016-001CAS 179545-77-8
Impurity(R)-TanomastatCat. No. P-T016-002CAS 179545-78-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.